AGM/EGMApr 29, 2026, 04:32 PM
BDTX 2026 Annual Meeting of Stockholders Announced
AI Summary
Black Diamond Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 26, 2026. Stockholders will vote on the election of two Class III director nominees, the ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026, and two non-binding advisory votes regarding executive compensation and its frequency. The board recommends voting for all proposals and for an annual frequency for executive compensation votes.
Key Highlights
- 2026 Annual Meeting of Stockholders to be held online on June 26, 2026, at 9:00 a.m. Eastern Time.
- Stockholders of record as of April 28, 2026, are eligible to vote.
- Proposals include electing two Class III director nominees.
- Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.
- Non-binding advisory vote on named executive officer compensation.
- Non-binding advisory vote on the frequency of future executive compensation votes, with a recommendation for 'ONE YEAR'.
Price Impact
More from BDTX